Plain-English translation of NCT06050200 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing three different methods to help patients with liver cancer or liver tumors by making the remaining liver larger and stronger before surgery. Some patients don't qualify for surgery because the part of the liver left behind after removing tumors would be too small. This study compares three approaches—including interventional radiology procedures and a surgical technique—to see which one best prepares patients for successful cancer removal.
Doctors know these three methods can help enlarge the remaining liver, but no one has directly compared them in a rigorous study to see which one is safest and most effective. Most importantly, previous research focused only on liver size, not actual liver function—but function is what truly matters for patient survival and recovery.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to one of three groups. One group will receive a minimally invasive procedure where doctors block a vein in your liver using imaging guidance. Another group will have a similar procedure but blocking both a portal vein and hepatic vein. The third group will have a surgical procedure where the surgeon ties off a vein branch and partially cuts the liver. After your assigned procedure, doctors will monitor your liver's growth and function using imaging and special scans before performing your cancer removal surgery.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Poland